Norwegian salmon producer Salmonor improved revenue last year, but saw margins fall on impacts from pancreatic disease (PD).
Operating profit for the group was down slightly to NOK 112.3 million (€12.2 million/$13.7 million) in 2014, from NOK 113.2 million (€12.3 million/$13.8 million) in 2013.
Salmonor increased its sales to NOK 430.7 million (€46.8 million/$52.5 million) last year from NOK 350.8 million (€38.2 million/$42.7 million) in 2013, however.
Net profit ended up at NOK 81.4 million (€8.9 million/$9.9 million), down from NOK 82.7 million (€9 million/$10.1
